LOS ANGELES and PORTLAND, Ore. — A Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who ...
Credit: Vall d'Hebron Institute of Oncology (VHIO). Presented at the 45th annual San Antonio Breast Cancer Symposium® (2022 SABCS®), ...
SAN ANTONIO – In patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of the investigational AKT ...
ABSTRACT LBA 05 Researchers from The University of Texas MD Anderson Cancer Center demonstrated that adding metastasis-directed radiation therapy to intermittent hormone ...
(Vienna, October 9, 2022) Eating a Mediterranean diet, rich in fibre, mono-unsaturated fatty acids and polyphenols, has been associated with ...
Credit: European Society for Medical Oncology First randomised study to show cell therapy improves outcomes in patients with solid ...
BOSTON – Patients with multiple myeloma who have been treated with a three-drug combination therapy have a growing number of ...
ABSTRACT LBA7502 Combination chemoimmunotherapy with the Bruton’s tyrosine kinase (BTK) inhibitor ibrutinib demonstrated improved progression-free survival over standard chemoimmunotherapy for ...
HOUSTON ― Patients with melanoma who reported eating more fiber-rich foods when they began immunotherapy treatment survived longer without cancer ...
Lugano, Switzerland, 20 September 2021 - The first randomised study in malignant pheochromocytoma and paraganglioma (MPP) has found that sunitinib prolongs progression-free survival (PFS) by more ...
